TROY supplier risk Q1-2026: 53 shipments, China-dominant sourcing, C-grade risk profile.
TROY processed 53 shipments across 3 suppliers in Q1 2026, sourcing from 2 countries. China dominated the import footprint at 34% of shipments, primarily through HEFEI JINGCHENG MEDSOURCE with 18 shipments. A minor Korean source of the same supplier name accounted for 1 shipment. No HS classification data was recorded for this period.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
TROY recorded zero sanctions watchlist hits in Q1 2026. No suppliers registered exposure to UFLPA forced-labor risk categories.
3 distinct tier-1 suppliers in Q1 2026
| HEFEI JINGCHENG MEDSOURCE | China | 18 |
| HEFEI JINGCHENG MEDSOURCE | South Korea | 1 |
Share of Q1 2026 inbound shipments by source country
110 tier-2 + 572 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.